Uncategorized
Aerie reports $28.4 million net loss in second quarter
Aerie Pharmaceuticals reported a net loss of $28.4 million, or $0.82 per share, in the second quarter of 2017 compared with a net loss of $23.2 million, or $0.87 per share, in the same quarter of 2016, according to a press release.Research and development expenses totaled $10.6 million compared with $13.3 million in 2016, and selling, general and administrative expenses were $17.2 million compared with $9.4 million.